Ministry of Attorney General
Lobbyists Activity Registration -
Organization
Registration ID: 946232
Submitted by lobbyist on: September 15, 2026 08:00 AM
Accepted by Registrar on: September 15, 2026 10:50 AM
Senior Officer Contact Information
| Surname: |
Hamelin
|
| First Name: |
Bettina
|
| Middle Name: |
Medicines
|
| Address: |
310-99 Bank Street
Ottawa, ON
K1P 6B9
Canada
|
| E-mail Address: |
mel-ghazal@imc-mnc.ca
|
| Phone Number: |
+1 343-999-2112
|
| Fax Number: |
|
Organization Information
| Name of organization: |
Innovative Medicines Canada (Médicaments novateurs Canada)
|
| Organization business or activity summary: |
Innovative Medicines Canada represents Canada's innovative pharmaceutical industry. We help our members discover, develop and deliver innovative medicines and vaccines. Our member companies, which range from early-stage startups to established organizations, are revolutionizing healthcare through the discovery and development of new medicines and vaccines. Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and other stakeholders to advance the field of pharmaceutical research and development and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada's healthcare system. We achieve our goals by forming alliances, supporting policies, improving Canada's regulatory environment, widening access to innovative medicines and ensuring the effective protection of intellectual property.
|
| Address: |
310-99 Bank Street
Ottawa, ON
K1P 6B9
Canada
|
| E-mail Address: |
mel-ghazal@imc-mnc.ca
|
| Phone Number: |
+1 343-999-2112
|
| Fax Number: |
|
Organization Lobbying Activity
| Registration start date: |
Locale not set
|
| Registration end date: |
Locale not set
|
Organization's Relevant Interfaces
Description of Organization
| Description of Organization: |
Innovative Medicines Canada is comprised of member companies that range from early-stage startups to established organizations and are revolutionizing healthcare through the discovery and development of new medicines and vaccines. The categories of memberships are: (a) Full membership, which is open to innovative pharmaceutical companies that research, develop, manufacture, and/or distribute pharmaceutical prescription preparations under their own labels in Canada;and(b)Life Sciences Association
|
| Name of Officer: |
Bourbara, Gaby
|
| Name of Officer: |
Laranjo, Michael
|
Corporation Information
| Name of Director: |
Alam, Javed
|
| Name of Director: |
Archibald, Jill
|
| Name of Director: |
Dybka, Ed
|
| Name of Director: |
Engel, Jody
|
| Name of Director: |
Gitas, Dimitri
|
| Name of Director: |
Gunaydin, Ugur
|
| Name of Director: |
Guy, James
|
| Name of Director: |
Jones, David
|
| Name of Director: |
McLay, Bob
|
| Name of Director: |
Merlet , Mathilde
|
| Name of Director: |
Reis, Rodrigo
|
| Name of Director: |
Stiff, Carol
|
| Name of Director: |
Van Gerven, An
|
Subsidiary Business Contact Information
| Business Name |
Mailing Address |
Phone Numbers and E-mail |
Controlling Corporation Business Contact Information
| Business Name |
Mailing Address |
Phone Numbers and E-mail |
Government or Government Agency Funding
Organization Lobbyists